Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,114.2
-12.0 (-0.38%)

 

  • STI Straits Times Index
    3,114.2
    -12.0 (-0.38%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.2
    -3.4 (-0.21%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,719.6
    -128.9 (-0.48%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,938.1
    -39.2 (-1.32%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,492.7
    40.8 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,191.9
    10.9 (0.18%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,060.7
    -17.2 (-0.83%)
    Index delayed 20 minutes
  • XAO XAO
    6,758.4
    -33.1 (-0.49%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 937.3M
  • Value: 879.2M
  • Rise: 114
  • Fall: 160
  • Unch: 558

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
MDR0.002-
Rex Intl0.093+0.005
ThaiBev0.900+0.025
Genting Sing0.915-0.010
Spackman0.016-
YZJ Shipbldg SGD0.940-0.010
Y Ventures0.112+0.001
AEM1.280+0.020
KLW0.003-
Singapore-eDev0.045-0.002

World Indices

World Indices
Name Last Change
Nasdaq 8,089.5 -67.3
HSI 26,719.6 -128.9
HSCEI 10,540.0 -48.1
Jakarta 6,191.9 +10.9
Nikkei 225 22,492.7 +40.8
SSE Comp 2,938.1 -39.2
Shanghai A 3,078.2 -41.1
Shanghai B 263.8 -3.3
PSE Comp 0.0
KOSPI 2,060.7 -17.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NOVABAY PHARMACEUTICALS INC NOVABAY PHARMACEUTICALS INC
Updated on 18 Oct 2019 (End of trading day)
Last (USD): 0.615 Change: -0.005 High: 0.620 Remarks: -
Change (%): -0.81 Low: 0.600
Open 0.610 Yesterday's Close 0.62
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 155,433 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.42753 Trailing EPS (USD) e -0.62218 NAV (USD) b 0.1090
PE a - Trailing PE f - Price / NAV b 5.6422
Dividend (USD) d - Cash In Hand (USD) g 0.2396 Issued & Paid-up Shares c 25,201,800
Dividend Yield (%) d - Price / Cash In Hand g 2.567 Treasury Shares h -
Beta - 75 Daysi 0.736 R-Squared - 75 Days(%)i 0.73 Market Cap (M) 9.415
Beta - 500 Daysi 0.710 R-Squared - 500 Days (%)i 0.02 Enterprise Value (M) 10.465
Piotroski F Score 4 Exchange Code NBY Par Value ( $ ) n.a.
52 Weeks Volatility (%) 226.73 Free Float (%) 53.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 26 Aug 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NOVABAY PHARMACEUTICALS INC NYSE American 9.415 - - 5.6422 -
Industry Biotechnology NYSE American 74.824 - - 2.6295 -
Local Peer PFENEX INC NYSE American 217.643 - - 4.2007 -
Local Peer 22ND CENTURY GROUP INC NYSE American 211.686 - - 3.3971 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 146.321 - 4.712 1.0969 -
Local Peer NAVIDEA BIOPHARMACEUTICALS INC NYSE American 129.766 - - 57.1429 -
Local Peer NANOVIRICIDES INC NYSE American 124.883 - - 11.7857 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 127.177 3.555 3.555 1.2649 -
Local Peer CEL-SCI CORP NYSE American 73.288 - - 63.9251 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 64.123 - - 2.0818 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 51.171 - - 10.0504 -
Local Peer IBIO INC NYSE American 48.312 - - 19.6415 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 40.332 - - 1.7823 -
Local Peer INDIA GLOBALIZATION CAPITAL INC NYSE American 31.183 - - 0.9619 -
Other Local Peers ORAGENICS INC (NYSE American), ISORAY INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AIM IMMUNOTECH INC (NYSE American)
Global Peer AMGEN INC NASDAQ 121,571.387 14.483 15.277 11.2628 2.734
Global Peer GILEAD SCIENCES INC NASDAQ 82,205.269 15.070 13.804 3.6348 3.556
Global Peer CSL ASX 113,904.993 42.456 42.456 15.2216 1.057
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CELGENE CORP NASDAQ 72,964.886 18.034 13.843 7.2595 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 45,297.278 21.607 20.450 8.9344 -
Global Peer ILLUMINA INC NASDAQ 45,487.680 55.070 48.494 10.5004 -
Global Peer BIOGEN INC NASDAQ 40,589.407 9.161 7.667 3.1336 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 32,989.185 13.496 15.943 3.3815 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,077.029 73.028 21.527 4.8614 0.821
Other Global Peers ALEXION PHARMACEUTICAL INC (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), SEATTLE GENETICS INC (NASDAQ), WUXI BIO (HKEx), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), 3SBIO (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), GENSCRIPT BIO (HKEx), SPARK THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), FIBROGEN INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ALKERMES PLC (NASDAQ), NATERA INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), 10X GENOMICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), INSMED INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), FRONTAGE (HKEx), MOMENTA PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), POLYNOVO LIMITED (ASX), DICERNA PHARMACEUTICALS INC. (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ALECTOR INC (NASDAQ), VIVA BIOTECH (HKEx), ANAPTYSBIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), EPIZYME INC (NASDAQ), HAOHAI BIOTEC (HKEx), CARA THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD (ASX), INTREXON CORP (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), OMEROS CORP (NASDAQ), KODIAK SCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), MESOBLAST LTD (ASX), ROCKET PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CORTEXYME INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), NEXTCURE INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), MACROGENICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ARVINAS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), RETROPHIN INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), CHEMOCENTRYX INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AVROBIO INC (NASDAQ), ASCLETIS-B (HKEx), STEMLINE THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), CKLIFE SCIENCES (HKEx), PROGENICS PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ESSEX BIO-TECH (HKEx), APREA THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), MERUS B V (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), PERSONALIS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), XBIOTECH INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), KADMON HLDGS INC (NYSE), DYNAVAX TECHNOLOGIES CORP (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), NEXT SCIENCE LTD (ASX), LEE'S PHARM (HKEx), HARPOON THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), DERMIRA INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), ARDELYX INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), GERON CORP (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), TELIX PHARMACEUTIC (ASX), EIGER BIOPHARMACEUTICALS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), RESTORBIO INC (NASDAQ), COMPUGEN (NASDAQ), SERES THERAPEUTICS (NASDAQ), MANNKIND CORPORATION (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), DPHARMA (Bursa), KAMADA (NASDAQ), CHIASMA INC (NASDAQ), ATHERSYS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), AFFIMED N V (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), BBI LIFE SCI (HKEx), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), X4 PHARMACEUTICALS INC (NASDAQ), UNI-BIO GROUP (HKEx), NABRIVA THERAPEUTICS PLC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), IMV INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), AXCELLA HEALTH INC (NASDAQ), SESEN BIO INC (NASDAQ), NANTKWEST INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), PHYLOGICA LIMITED (ASX), HARVARD BIOSCIENCE INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), VBI VACCINES INC CDA (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), TREVENA INC (NASDAQ), CHIMERIX INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), VACCINEX INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ARAVIVE INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), IMMUTEP LTD (ASX), CURIS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), PORT (SET), NEON THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), EQUILLIUM INC (NASDAQ), ORGENESIS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), IMUGENE LIMITED (ASX), ARBUTUS BIOPHARMA CORP (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), CT ENTERPRISE (HKEx), VISTAGEN THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ORTHOCELL LIMITED (ASX), NEWLINK GENETICS CORP (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), INMUNE BIO INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), VERMILLION INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), BIONOMICS LTD (ASX), IVERIC BIO INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), SURFACE ONCOLOGY INC (NASDAQ), SAVARA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), MEMPHASYS LTD (ASX), REGENT PACIFIC (HKEx), DIAMEDICA THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), BIOTRON (ASX), ACTINOGEN MEDICAL LTD (ASX), RHINOMED LIMITED (ASX), ZAFGEN INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), BIOCARDIA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), CONTRAFECT CORP (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), BIOSINO BIO-TEC (HKEx), SIERRA ONCOLOGY INC (NASDAQ), SENESTECH INC (NASDAQ), EXTRAWELL PHAR (HKEx), AZURRX BIOPHARMA INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED (ASX), AETERNA ZENTARIS INC (NASDAQ), SOLIGENIX INC (NASDAQ), OCUGEN INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), CO DIAGNOSTICS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), BIOCEPT INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PATRYS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), ADALTA LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), BIONANO GENOMICS INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), REGENEUS LTD (ASX), PRECIPIO INC (NASDAQ), IMMURON LIMITED (ASX), VAXART INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TOCAGEN INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PULMATRIX INCORPORATED (NASDAQ), Suntar Eco-City^ (SGX), ATYR PHARMA INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), ONCOLYTICS BIOTECH INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), CELLMID LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), MEDIBIO LIMITED (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BIOXYNE LIMITED (ASX), HAO WEN HLDGS (HKEx), ADVAXIS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), ARCA BIOPHARMA INC (NASDAQ), MGRC (Bursa), TRILLIUM THERAPEUTICS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), MEGASUN (Bursa), TROVAGENE INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), TBG DIAGNOSTICS LTD (ASX), PROTEON THERAPEUTICS INC (NASDAQ), OPGEN INC (NASDAQ), QT Vascular (SGX), CCP TECHNOLOGIES LTD (ASX), NANOLLOSE LTD (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), NOVITA HEALTHCARE LTD (ASX), SPHERIX INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), NEURALSTEM INC (NASDAQ), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), FACTOR THERAPEUTICS LIMITED (ASX), PLUS THERAPEUTICS INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.003
-0.49 %
10 Days -+0.039
+6.77 %
20 Days --0.075
-10.87 %
Medium Term Return 3 Months --0.535
-46.52 %
6 Months --0.485
-44.09 %
1 Year --0.935
-60.32 %
Long Term Return 2 Years --3.685
-85.70 %
3 Years --3.305
-84.31 %
5 Years --19.385
-96.92 %
Annualised Return Annualised --
-50.16 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.229 - 4.040 Change From 1 Year Low +0.386 % Change From 1 Year Low (%) +168.56
Change From 1 Year High -3.425 % Change From 1 Year High (%) -84.78
2 Years Range 0.229 - 4.800 Change From 2 Years Low +0.386 % Change From 2 Years Low (%) +168.56
Change From 2 Years High -4.185 % Change From 2 Years High (%) -87.19
5 Years Range 0.229 - 26.250 Change From 5 Years Low +0.386 % Change From 5 Years Low (%) +168.56
Change From 5 Years High -25.635 % Change From 5 Years High (%) -97.66
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
18 Oct 2019 0.610 0.620 0.600 0.615 155,433 -
17 Oct 2019 0.615 0.640 0.604 0.620 154,717 -
16 Oct 2019 0.640 0.660 0.610 0.630 291,582 -
15 Oct 2019 0.610 0.635 0.610 0.633 158,774 -
14 Oct 2019 0.620 0.639 0.604 0.625 164,575 -
11 Oct 2019 0.601 0.640 0.601 0.618 142,483 -
10 Oct 2019 0.625 0.670 0.600 0.627 267,253 -
09 Oct 2019 0.600 0.670 0.585 0.649 384,897 -
08 Oct 2019 0.607 0.625 0.580 0.607 144,501 -
07 Oct 2019 0.577 0.620 0.577 0.604 183,049 -
04 Oct 2019 0.563 0.620 0.523 0.576 547,900 -
03 Oct 2019 0.579 0.590 0.535 0.558 191,266 -
02 Oct 2019 0.560 0.594 0.510 0.590 512,226 -
01 Oct 2019 0.605 0.610 0.522 0.560 792,146 -
30 Sep 2019 0.650 0.650 0.605 0.610 342,419 -
27 Sep 2019 0.660 0.666 0.620 0.652 375,701 -
26 Sep 2019 0.660 0.680 0.623 0.644 562,474 -
25 Sep 2019 0.670 0.685 0.600 0.640 1,119,864 -
24 Sep 2019 0.800 0.816 0.662 0.681 3,284,979 -
23 Sep 2019 0.690 0.710 0.630 0.680 814,339 -
20 Sep 2019 0.710 0.775 0.641 0.690 2,195,013 -
19 Sep 2019 0.800 0.818 0.680 0.786 6,108,678 -
Summary
Current 2 Weeks
(07 Oct 2019 to 18 Oct 2019)
0.577 0.670 0.577 0.615 2,047,264 -
Previous 2 Weeks
(23 Sep 2019 to 04 Oct 2019)
0.690 0.710 0.577 0.576 8,543,314 -
4 Weeks from
(23 Aug 2019 to 20 Sep 2019)
0.689 0.689 0.577 0.690 37,460,625 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.